SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 6/21/2017 1:09:10 PM - Followers: 32 - Board type: Free - Posts Today: 0
BMY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY News: Four-Year Follow-up with Empliciti (elotuzumab) Plus Lenalidomide/Dexamethasone (ELd) in Patients with Advanced Multiple Myel... 06/24/2017 10:00:00 AM
BMY News: S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 06/21/2017 10:00:00 AM
BMY News: Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer 06/21/2017 06:59:00 AM
BMY News: Bristol-Myers Squibb Announces the Pricing Terms of its Cash Tender Offer For Any & All of Certain of its Outstanding Debt Se... 06/20/2017 03:40:00 PM
BMY News: Extended Follow-Up Data Evaluating Opdivo (nivolumab) Shows Durable Response in Adult Patients with Relapsed or Progressed... 06/16/2017 06:58:00 AM
PostSubject
#499  Sticky Note CC transcript from Seeking Alpha: chmcnfunds 04/27/17 03:30:00 PM
#542   Presumed source probably was CNA Finance, but their chmcnfunds 06/21/17 01:09:10 PM
#541   LOL—no mention of the actual source. The Seeking DewDiligence 06/21/17 01:03:21 PM
#540   Source of rumor alluded to by SA: chmcnfunds 06/21/17 11:29:47 AM
#539   Takeover rumors de jour: Pfizer taking out Bristol-Myers, chmcnfunds 06/21/17 11:13:43 AM
#538   Companies Get New Suit Limits as Supreme Court chmcnfunds 06/19/17 12:56:30 PM
#537   Motley Fool article: chmcnfunds 06/16/17 12:09:51 PM
#536   6 days to gain back the 2 day chmcnfunds 06/14/17 01:33:03 PM
#535   Strange trade, cancelled and made again: chmcnfunds 06/08/17 08:48:18 AM
#534   Big trade pm: chmcnfunds 06/08/17 08:34:47 AM
#533   BMY ASCO2017 Investor Event: chmcnfunds 06/05/17 09:51:36 AM
#532   Bristol-Myers' Opdivo/Yervoy combo shows positive effect in metastatic chmcnfunds 06/05/17 09:21:50 AM
#531   A LAG-3, Opdivo combo from Bristol-Myers offers a chmcnfunds 06/05/17 08:52:57 AM
#530   Hope so -- soon. But down ~ 2.4% chmcnfunds 06/05/17 08:40:23 AM
#529   Maybe back to $60+? 2014shelby 06/03/17 07:01:46 PM
#528   If BMY was purely a technical play the chmcnfunds 06/02/17 12:03:24 PM
#527   Merck reports positive results for late-stage trial comparing chmcnfunds 06/02/17 08:02:17 AM
#526   Bristol-Myers and Seattle Genetics advance Opdivo/Adcetris combo for chmcnfunds 06/02/17 07:23:31 AM
#525   Impossible to decipher this stock. Yesterday by all chmcnfunds 05/25/17 03:28:33 PM
#524   U.S. Food and Drug Administration Accepts for Priority chmcnfunds 05/24/17 11:22:12 AM
#523   Bristol-Myers Squibb (BMY) Management Presents at UBS Global chmcnfunds 05/23/17 08:22:43 AM
#522   Health Canada approves OPDIVO® (nivolumab) for the treatment chmcnfunds 05/17/17 08:26:54 AM
#521   Wrong day for this blog, but has all chmcnfunds 05/16/17 02:30:35 PM
#520   Thanks, had seen that, but wasn't thinking it chmcnfunds 05/12/17 03:02:58 PM
#519   BMY slightly down due to AZN news in DewDiligence 05/12/17 02:55:55 PM
#518   Strange day. BMY usually trades in coordination with chmcnfunds 05/12/17 02:49:15 PM
#517   Roche's Loss In Bladder Cancer Lifts Astrazeneca and chmcnfunds 05/10/17 09:19:57 AM
#516   Suppose this shouldn't have impact on BMY, but FWIW: chmcnfunds 05/09/17 01:21:10 PM
#515   JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals chmcnfunds 05/05/17 02:15:58 PM
#514   You must be referencing the SA article from chmcnfunds 05/04/17 08:20:27 AM
#513   PFE may not be in the cards as 2014shelby 05/03/17 09:37:10 PM
#512   I'll leave it to the analysts who have chmcnfunds 05/03/17 08:09:36 AM
#511   What PPS do you think PFE would BO BMY? 2014shelby 05/02/17 09:31:24 PM
#510   Rumors persist: chmcnfunds 05/02/17 12:36:29 PM
#509   It's unlikely, IMO, that there will be a DewDiligence 05/01/17 06:42:10 PM
#508   Speculation prior to PFE earnings: chmcnfunds 05/01/17 03:17:08 PM
#507   Yes, but there are only a few companies DewDiligence 04/28/17 09:09:07 PM
#506   Do you think BMY is a BO candidate? 2014shelby 04/28/17 08:23:45 PM
#505   This isn't really newsworthy since the EU Commission DewDiligence 04/28/17 03:42:34 PM
#504   More good news. pps should be flying: chmcnfunds 04/28/17 03:39:10 PM
#503   Tom Lynch outlines his comeback strategy for Bristol-Myers’ chmcnfunds 04/28/17 01:22:25 PM
#502   Had noticed and was surprised that the revised chmcnfunds 04/28/17 08:38:38 AM
#501   Good news keeps coming. Surprised to see it chmcnfunds 04/28/17 08:30:18 AM
#500   PR excerpt pertaining to 2017 EPS guidance: DewDiligence 04/27/17 05:24:53 PM
#499   CC transcript from Seeking Alpha: chmcnfunds 04/27/17 03:30:00 PM
#498   Bristol-Myers Q1 top line up 12%; Opdivo sales chmcnfunds 04/27/17 09:11:54 AM
#497   Bristol-Myers Squibb Reports First Quarter Financial Results chmcnfunds 04/27/17 07:53:19 AM
#496   A ~ 40' interview of Dr. Jedd Wolchok, north40000 04/25/17 09:50:24 PM
#495   Last trade on 4/24/17: chmcnfunds 04/25/17 07:32:48 AM
#494   BMY presents positive phase-2 data BMS-986036: #msg-130715323. DewDiligence 04/22/17 03:32:45 PM
#493   See #msg-130693584 for additional color on today's approval. DewDiligence 04/21/17 02:45:39 PM
PostSubject